FGF21 and obesity due to melanocortin 4 receptor deficiency: Serum FGF21 levels are significantly increased in individuals with T2DM and obesity, which can be deleterious for sarcopenic individuals with physical frailty (Zhang et al., 2008; Chen et al., 2011; Xiao et al., 2012).